Participants

P

Patients underwent palliative care or treatment for life-threatening illnesses with no age restrictions. Family members of patients may be included if they are sole participants.

Intervention

I

Any direct or indirect use of ePROMs in the treatment or plan in CP or CFL, including (but not limited to) comfort measures, symptom/suffering relief, side effect atonement, symptom assessment, coping assessment, QOL assessment, QOC assessment, prognostic evolution, and CP introduction/intervention decision.

Context

C

Palliative care, end of life, life-threatening illnesses.

Outcomes

O

Any outcome including (but not limited to) outcomes directly or indirectly related to the use of ePROMs in quality of life modifiers, disease progression, PC intervention, symptom burden assessment/modifier.

Design

D

Any peer-reviewed studies including (but are not limited to) questionnaires in the clinical setting, randomized clinical trials, controlled clinical trials, web-based surveys (following CHERRIES), secondary analyses, integrated knowledge translations, exploratory analyses, feasibility studies, prospective randomized studies.